Age-dependent alpha-synuclein aggregation and Lewy body formation in Parkinson’s disease

Age-dependent alpha-synuclein aggregation and Lewy body formation in Parkinson’s disease

Saved in:

Bibliographic Details
Main Authors:	Chun Chau Sung, Kenny K. K. Chung
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-12-01
Series:	Neural Regeneration Research
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-00772
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
by: D. Luke Fischer, et al.
Published: (2025-01-01)

Blood Plasma of Patients with Parkinson’s Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity
by: Peng Wang, et al.
Published: (2016-01-01)

Alpha synuclein and inflammaging
by: Geneviève L. Putnam, et al.
Published: (2025-01-01)

Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional studyResearch in context
by: Kenneth Marek, et al.
Published: (2025-02-01)

Detection of Phosphorylated Alpha-Synuclein in the Muscularis Propria of the Gastrointestinal Tract Is a Sensitive Predictor for Parkinson’s Disease
by: Goichi Beck, et al.
Published: (2020-01-01)

Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice
by: Sonja Mendritzki, et al.
Published: (2010-01-01)

Alpha synuclein overexpression can drive microbiome dysbiosis in mice
by: Timothy R. Sampson, et al.
Published: (2025-02-01)

Cortical Lewy Body Dementia
by: W. R. G. Gibb
Published: (1990-01-01)

Lewy body diseases and the gut
by: Timothy R. Sampson, et al.
Published: (2025-01-01)

The Contribution of α-Synuclein Spreading to Parkinson’s Disease Synaptopathy
by: Francesca Longhena, et al.
Published: (2017-01-01)

Motor cortical neuronal hyperexcitability associated with α-synuclein aggregation
by: Liqiang Chen, et al.
Published: (2025-01-01)

Spatial Perseveration in Dementia with Lewy Bodies
by: Frédéric Assal, et al.
Published: (2007-01-01)

Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins
by: Anna-Sophia Hartke, et al.
Published: (2025-02-01)

The effect of AKT inhibition in α-synuclein-dependent neurodegeneration
by: Bedri Ranxhi, et al.
Published: (2025-02-01)

Novel Poly-Arginine Peptide R18D Reduces α-Synuclein Aggregation and Uptake of α-Synuclein Seeds in Cortical Neurons
by: Emma C. Robinson, et al.
Published: (2025-01-01)

Behavioural and Cognitive Changes in Lewy Body Dementias
by: Woon-Man Kung, et al.
Published: (2018-01-01)

Postmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain
by: Alexandra Dumitriu, et al.
Published: (2012-01-01)

Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis
by: Simone A. van den Berge, et al.
Published: (2012-01-01)

αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson’s Disease?
by: David Protter, et al.
Published: (2012-01-01)

Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson’s Disease
by: Jianshe Wei, et al.
Published: (2021-01-01)

Cognitive profile in mild cognitive impairment with Lewy bodies
by: Shuai Liu, et al.
Published: (2023-08-01)

High-Affinity Detection of Alpha-Synuclein by Aptamer-Gold Conjugates on an Amine-Modified Dielectric Surface
by: Xuemei You, et al.
Published: (2019-01-01)

Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First?
by: Michela Zaltieri, et al.
Published: (2015-01-01)

Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease
by: Faustine Lelan, et al.
Published: (2011-01-01)

White matter hyperintensities and cholinergic degeneration as Lewy body disease
by: Sungwoo Kang, et al.
Published: (2025-01-01)

Brain network and energy imbalance in Parkinson’s disease: linking ATP reduction and α-synuclein pathology
by: Hirohisa Watanabe, et al.
Published: (2025-01-01)

Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination
by: Jing Gao, et al.
Published: (2025-02-01)

REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB)
by: Po-Chi Chan, et al.
Published: (2018-01-01)

Preclinical Polymodal Hallucinations for 13 Years before Dementia with Lewy Bodies
by: Carlo Abbate, et al.
Published: (2014-01-01)

Essential Oils May Lead α-Synuclein towards Toxic Fibrils Formation
by: Dina Morshedi, et al.
Published: (2016-01-01)

Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
by: James A. Wiseman, et al.
Published: (2025-02-01)

Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson’s disease
by: Stefan Bräuer, et al.
Published: (2025-01-01)

Idiopathic REM Sleep Behavior Disorder: Implications for the Pathogenesis of Lewy Body Diseases
by: Tomoyuki Miyamoto, et al.
Published: (2011-01-01)

An overview of methods for the treatment and diagnosis of dementia with Lewy bodies. Clinical case analysis
by: M. Š. Markevičiūtė, et al.
Published: (2020-12-01)

DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson’s Disease Rat Model
by: Lingyu Zhang, et al.
Published: (2022-01-01)

Metabolic Risk Factors of Alzheimer’s Disease, Dementia with Lewy Bodies, and Normal Elderly: A Population-Based Study
by: Chih-Kuang Cheng, et al.
Published: (2018-01-01)

Association of Alzheimer’s and Lewy body disease pathology with basal forebrain volume and cognitive impairment
by: Julia Schumacher, et al.
Published: (2025-01-01)

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
by: Katharina Bolsewig, et al.
Published: (2025-01-01)

Exposition Lewis Hine
by: Jean Kempf
Published: (2013-12-01)

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01)